10–20 × 106 cells were portioned off and sorted based
on GFP expression only. The remaining cells were sorted based on GFP positivity,
as well as target expression using an APC fluorescent antibody targeting either
IL2RA (CD25) (Tonbo, catalog no. 20–0259-T100), IL-2 (Biolegend, catalog
no. 500310) or CTLA4 (Biolegend, catalog no. 349908). All antibodies were used
at a 1:25 dilution for staining. Cells sorted for IL2RA underwent surface
staining according to the manufacturer’s protocol. Cells sorted for IL-2
were treated with Cell Activation Cocktail with Brefeldin A (Biolegend, catalog
no. 423304) for 4 h before fixation, and were fixed using the BD
Cytofix/Cytoperm kit (Becton Dickinson, catalog no. 554714) according to the
manufacturer’s protocol. Cells sorted for CTLA4 were treated with Cell
Activation Cocktail without Brefeldin A (Biolegend, catalog no. 423302) for 4 h
before fixation, and were fixed using the Foxp3 Fix/Perm buffer set (Biolegend,
catalog no. 421403) according to the manufacturer’s protocol. Cells were
sorted using a BD FACS Aria II and FACSDiva v.8.0.1.